Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…
Bausch + Lomb Launches Preservative-Free Version of LUMIFY Eye Drops in the U.S.
LUMIFY just leveled up. Meet the preservative-free formula sensitive, red-eye patients need. On May 21, 2025, Bausch + Lomb (Laval,…
latest posts
